tiny market cap about to pop

This is an easy double on FDA approval. Potential is truly breathtaking - could be trading around $2 by the end of the year.

Anyway, first things first. I expect FDA approval to come in early September, and a re-rating around the 25 - 30 cent mark. This technology will be massive. A takeover may well spoil the party, but it will have to come at a hefty premium now that the cat is out of the bag.